ACC 2026
Monthly Injection Lowers Blood Pressure Protein, But Leaves Blood Pressure Question Unanswered
Phase 2 trial of tonlamarsen in resistant hypertension: the drug’s
Saif Quadri
April 7, 2026
Phase 2 trial of tonlamarsen in resistant hypertension: the drug’s
STEMI-DTU trial: Delayed reperfusion with LV unloading shows no significant
Long-awaited survival data from the ARTO trial have confirmed that
A prospective single-surgeon series has demonstrated that the Lisbon Zero-Clip
A single-institution study from the University of California, Irvine has
A large prospective multicentre registry study has identified a comprehensive
A multicentre retrospective series from Mexico has reported that radical
A landmark international survey spanning 93 countries and more than
A large, multicentre randomised controlled trial comparing conventional laparoscopic and
The comprehensive study was presented on Monday, September 15th, 2025
The research study was presented on Monday, September 15th, 2025
The comprehensive study was presented on Monday, September 15th, 2025